The overall aim of this pilot study is to prospectively monitor programmed death-ligand 1 (PD-L1) expression dynamics in vivo, during neoadjuvant chemoradiotherapy (CRT) or short-course preoperative radiotherapy (SCPRT) in rectal and esophageal cancer by a positron emission tomography (PET) imaging approach.

Description:

Programmed Death-ligand 1 Positron Emission Tomography Imaging During Neoadjuvant (Chemo)radiothErapy in Esophageal and Rectal Cancer (PETNEC): a Prospective Non-randomized Open-label Single-center Pilot Study

Sponsor:

Johannes Laengle, MD, PhD

Contacts:

Johannes Laengle, MD, PhD

johannes.laengle@meduniwien.ac.at

+43140400 69260

Michael Bergmann, MD

michael.bergmann@meduniwien.ac.at

+43140400 69260

Government Study Link:

NCT04564482 - Click here to see study on

ClinicalTrials.gov

Contact XCancer: 402-991-8468